Post‐transplant adjustment – The later years by Fredericks, Emily M. et al.
Review Article
Post-transplant adjustment – The later years
Fredericks EM, Zelikovsky N, Aujoulat I, Hames A, Wray J. (2014)
Post-transplant adjustment – The later years. Pediatr Transplant, 18:
675–688. DOI: 10.1111/petr.12366.
Abstract: As survival rates for pediatric solid organ transplantation
have continued to improve, researchers and healthcare providers have
increasingly focused on understanding and enhancing the HRQOL and
psychosocial functioning of their patients. This manuscript reviews the
psychosocial functioning of pediatric transplant recipients during the
“later years,” deﬁned as more than three yr post-transplant, and
focuses on the day-to-day impact of living with a transplant after the
immediate period of adjustment and early years after surgery. Key
topics reviewed include HRQOL, cognitive functioning, impact on the
family, regimen adherence, and transition of responsibility for self-
management tasks. Overall, pediatric transplant recipients evidence
impairment in HRQOL, neuropsychological outcomes, and family
functioning as compared to non-transplant recipients. However, the
degree of impairment is inﬂuenced by a variety of factors including,
disease severity, age, solid organ type, and study methodologies.
Studies are limited by small samples, cross-sectional design, and the
lack of universal assessment battery to allow for comparisons across
solid organ populations. Areas for future research are discussed.
Emily M. Fredericks1, Nataliya
Zelikovsky2, Isabelle Aujoulat3, Anna
Hames4 and Jo Wray5
1Department of Pediatrics, University of Michigan,
C.S. Mott Children’s Hospital, Ann Arbor, MI, USA,
2Department of Psychology, La Salle University, The
Children’s Hospital of Philadelphia, Philadelphia, PA,
USA, 3Universite Catholique de Louvain, Institute of
Health & Society (IRSS), Brussels, Belgium, 4Institute
of Liver Studies, King’s College Hospital, London,
UK, 5Critical Care and Cardiorespiratory Division,
Great Ormond Street Hospital for Children, London,
UK
Key words: adolescents – adherence – health-
related quality of life – psychological adjustment
Emily M. Fredericks, Division of Child Behavioral
Health and Child Health Evaluation and Research
(CHEAR) Unit, University of Michigan and C.S. Mott
Children’s Hospital, 300 North Ingalls 6E18, Ann
Arbor, MI 48109-5456 USA
Tel.: 734 615 3866
Fax: 734 764 2599
E-mail: emfred@med.umich.edu
Accepted for publication 29 August 2014
As survival rates for pediatric solid organ trans-
plantation have continued to improve, research-
ers and healthcare providers have increasingly
focused on understanding and enhancing the
HRQOL and psychosocial functioning of their
patients. Furthermore, as ﬁve-yr graft survival
rates for liver, kidney, and heart transplant are
nearing 80% (1–3), researchers and clinicians
have been able to start addressing HRQOL in
the later years after transplant, which, depending
on the age of the child at transplant, can encom-
pass early childhood through to adolescence.
The ﬁve-yr graft survival rates for pediatric lung
(4) and intestine transplant recipients (5) are gen-
erally lower, yet long-term outcomes in these
groups are also improving. This manuscript will
review the psychosocial functioning of pediatric
transplant recipients during the “later years,”
deﬁned as more than three yr post-transplant,
and will focus on the day-to-day impact and real-
ity of living with a transplant after the immediate
period of adjustment and early years after
surgery.
An initial literature search was conducted to
identify key topics related to the later years post-
transplant, using keywords such as “pediatric
transplant by each the content domains includ-
ing: QoL, HRQOL, adjustment, psychological
adjustment/functioning, family functioning, par-
ent adjustment, as well as more speciﬁc search
terms related to mood (depression, anxiety),
Abbreviations: ALL, acute lymphoblastic leukemia;
BASC-2, behavior assessment system for children; CHQ,
child health questionnaire; HRQOL, health-related quality
of life; PedsQL, pediatric quality of life inventoryTM; PTSD,
post-traumatic stress disorder; QoL, quality of life; s.d.,
standard deviations; STEM, sociocultural transplant experi-
ence model; VAD, ventricular assist device; WISC-IV,
Wechsler intelligence scales for children.
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behavior, social functioning, neuropsychologi-
cal/cognitive/academic achievement functioning,
adherence, and transition. Searches were also
conducted by organ groups separately (i.e., kid-
ney/renal, heart/cardiac, lung, liver, pancreas,
small bowel). Articles were eliminated if they
were (i) studies that were only focused on physi-
cal functioning rather than psychological
(medical comorbidities/infections or medical
indicators like GFR, BP, BMI), (ii) adjustment
of organ donors rather than organ recipients, (iii)
studies that were performed with adult organ
recipients, (iv) studies of transplant recipients
within the pretransplant period or the ﬁrst three
yr post-transplant, (v) abstracts without full pub-
lished articles.
There is some limited work on long-term
transplant survivors who reach adolescence and
this is reviewed within the context of more gen-
eral adolescent issues. Transition to adult ser-
vices was also identiﬁed but as this is the focus of
a later manuscript in this series of articles it will
not be addressed in detail in the current article.
In many articles considered during this review,
authors did not specify particular periods of fol-
low-up but reported cross-sectional evaluation of
patient groups with variable follow-up, often
ranging from a few months to several years.
Where possible, ﬁndings referring to the later
years after transplant have been teased out, but
in some instances, this was not possible. Areas
for future research are suggested.
HRQOL
The majority of research in recent years has been
in discerning the degree of HRQOL relative to
healthy controls, with a few studies documenting
HRQOL compared to functioning prior to the
transplant and relative to other chronic illness
groups. Most often, studies of HRQOL in pedi-
atric solid organ transplant recipients are based
on parent reports, which may diﬀer from child
self-report with regard to degree of perceived
functioning as well as speciﬁc domains that are
impacted. Furthermore, majority of the studies
published examined HRQOL in liver transplant
patients and to a lesser degree in heart and kid-
ney patients; similar research is almost non-exis-
tent with other organ groups. It is possible that
there are important diﬀerences in HRQOL
across organ types (6), underscoring the impor-
tance of continued work in this area.
Although there is documented improvement in
QoL after children receive an organ transplant,
about a third of the recipients remain at risk for
experiencing adjustment diﬃculties over the
years (7, 8). For instance, heart transplant recipi-
ents (mean age = 10.6 + 4.7 yr; time interval
since transplant 6.0  4.1 yr), liver transplant
recipients (mean age = 8.17  4.43 yr; 1 to 13 yr
post-transplant with median time 3.10 yr), and
kidney transplant recipients (median time since
transplant 3.2 yr) reported poorer HRQOL than
did healthy controls (9–11). These studies consis-
tently point to lower QoL as perceived by trans-
plant recipients across the solid organ groups.
Prevalence rates of signiﬁcantly impaired
HRQOL (deﬁned as scores of more than one
standard deviation below the population mean
for healthy norms) range from approximately
31% (9, 10) to 44% (12). Although to varying
degrees, parents of solid organ transplant recipi-
ents similarly perceive their children to experi-
ence challenges over time (13). For example, in a
recent study of 47 liver transplant recipients at a
mean time of 6.2 yr (3.9 yr) post-transplant
approximately 40% of parents surveyed indi-
cated that their children had lower HRQOL
scores on the PedsQL (a generic HRQOL mea-
sure) in addition to sleep-disordered breathing,
excessive daytime sleepiness, and sleep-related
syndromes (12).
Research has attempted to identify the areas
of functioning that seem to be most challenging
for transplant patients. Fredericks and colleagues
noted lower HRQOL in the domains of overall
functioning, physical and psychosocial health, as
well as social and school functioning, with fairly
consistent ﬁndings on the PedsQL and CHQ
measures (14). Focusing speciﬁcally on the
adolescent liver transplant patients (mean age =
15  1.9 yr; average time interval since trans-
plant 7.5  5.7 yr) revealed similarly impaired
HRQOL relative to published norms, particu-
larly in overall functioning as well as problems
on the psychosocial health and school domains
(15). Parent reports of adolescent functioning
were also lower across domains on the CHQ-
PF50 measuring self-esteem, general health per-
ceptions, parental impact and family activity
scales, as well as across emotional, social, and
physical domains of the PedsQL (15). Other
researchers found that the primary impact on
HRQOL as reported by parents was within the
physical domain, with the total psychosocial
scores comparable to the norms (13). Overall,
concerns with physical appearance, the experi-
ence of symptoms, diﬃculty with peer and family
interactions, and school disruption seem to aﬀect
pediatric recipients for years following transplan-
tation (11).
Several studies compared pediatric organ
transplant recipients to individuals with other
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chronic health conditions, rather than to healthy
controls. Liver transplant patients who were up
to ﬁve yr from transplant endorsed a level of
HRQOL that was comparable to renal trans-
plant recipients, but better than children with
rheumatologic disease (16), and lower than chil-
dren with diagnoses of cancer (14) and diabetes
(14, 16). Another study conducted in Norway
compared pediatric renal transplant recipients
(2–16 yr post-transplant; median interval since
transplant 4.9 yr) to patients diagnosed with
ALL and found that transplant patients were at
risk for more mental health problems and lower
HRQOL (17). Others, however, did not ﬁnd sig-
niﬁcant diﬀerences between transplant recipients
and children with other chronic illnesses. In a
study of 77 liver transplant patients evaluated
with the PedsQL and CHQ-PF50 at a mean of
5.8  3.8 yr after transplant, liver recipients had
comparable scores to that of other pediatric
chronic illness groups on most domains of
HRQOL and health status, with the exception of
social and school areas in which liver transplant
patients had lower functioning (18). In another
study, liver transplant survivors fared similarly
to patients with cancer with regard to social and
school functioning and even better on domains
of physical functioning (10).
Correlates of HRQOL
Studies have documented demographic and med-
ical variables that may impact HRQOL among
transplant recipients. Speciﬁcally, HRQOL has
been positively correlated with older age, longer
time since transplant, and fewer comorbid medi-
cal conditions (18–20). A recent study conducted
in Finland examined the long-term HRQOL and
psychosocial adjustment in organ transplant
patients up to 15 yr post-transplant (mean age
11.5 yr; mean time since transplant 7 yr) and
found that pre-adolescent patients endorsed
worse HRQOL than adolescent patients, as did
those who were fewer years since transplant (20).
Similarly, younger age at transplant has been
associated with lower scores in intestinal trans-
plant patients (21). In contrast, others reported
that younger age at the time of the transplant
was associated with better coping and adjust-
ment than in those transplanted later (22, 23),
suggesting that they were more likely to view the
condition as part of their normal development.
Additionally, family related variables (parental
QoL, whether patient lived with both parents or
in a single parent home, maternal education)
were associated with HRQOL outcomes (18–20).
Existence of comorbid diagnoses (psychiatric,
neurological comorbidities, acquired disease)
and speciﬁc medical variables (being on antisei-
zure medications, longer hospital days, frequency
of medical appointments, rejection episodes)
were predictive of poorer psychosocial adjust-
ment such as increased prevalence of somatic
complaints and internalizing problems (19, 20,
24). These demographic and medical variables
appear to be consistently salient in their associa-
tion with HRQOL, perhaps above and beyond
the contribution of baseline levels of HRQOL
(24).
Few studies have investigated behavioral and
psychological factors that may be related to
post-transplant QoL. In a study of 66 adolescent
and young adult heart, kidney, liver, and double-
lung recipients seen on two occasions after trans-
plant, 18 months apart, the best predictor of
HRQOL in the domains of physical QoL, mental
health and general health perceptions was the
baseline functioning in those same domains
(median age at baseline = 15.8  2.4 yr; median
interval since transplant 3.79 yr) (24). Adherence
to the prescribed regimen has also been linked to
HRQOL (15) and emotional adjustment (anxi-
ety, hope, illness, uncertainty) among adolescent
transplant patients (25, 26). Adolescents who
were determined to be non-adherent reported
lower HRQOL, particularly in health percep-
tions, self-esteem, mental health, and family
cohesion, as well as limitations in social and
school activities related to physical, emotional,
and behavioral problems (15). The only study to
examine sleep issues in the transplant population
found that sleep-related problems accounted for
a signiﬁcant portion of variance in the psychoso-
cial, physical, and total domains of the PedsQL
as perceived by parents, as well as school func-
tioning as reported by the children (12). Sleep
issues are not commonly reported in the litera-
ture, but seem to inﬂuence overall adjustment
and QoL. Although few in number, these studies
provide potential areas for further exploration.
Long-term HRQOL: 10–20 yr post-transplant
Several studies have recently examined adjust-
ment and functioning of pediatric patients up to
10–20 yr after the transplant surgery. Most of
the long-term follow-up has been conducted with
liver transplant recipients, who have been found
to have signiﬁcantly lower scores on HRQOL
measures, particularly on physical domains, even
when mental health domains were comparable to
the general population (18, 23, 27, 28). A large
Canadian sample (27) of 167 patients surviving
liver transplant by 10 yr (median time interval
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8.97 yr) reported signiﬁcantly lower HRQOL
scores on the PedsQL, with 14% of the patients
endorsing functioning that was 2 s.d. below the
healthy population norm. There are some mixed
ﬁndings, however, with possible diﬀerences in
long-term outcomes across organ groups. For
example, in contrast to ﬁndings above regarding
liver transplant participants, young adults aged
18–34 yr who had a heart transplant (mean time
16.2  3.0 yr post-transplant) (29) or a kidney
transplant (median time interval since transplant
7.4 yr; range 1.7–16.9 yr) (30) in childhood were
reported to have fairly good QoL. They endorsed
levels of functioning comparable to healthy
norms across physical and mental health
domains and perceived social support, despite
experiencing some medical complications, re-
transplantation, and acute rejections, suggesting
resilience over a long period of time.
It is also noteworthy that survivors up to 20 yr
post-organ transplant maintained active produc-
tive lives as young adults. Functioning at this age
may be gauged by indices such as the level of
schooling achieved and ability to maintain a job.
Speciﬁcally, studies indicated that most have
completed high school (74%) (23) and attended
college (63%) (28) or were employed (20–50%)
(28, 30); 35.4% were engaging in regular physical
activity (30), and about a third of the young
adults got married (23). Despite reporting signiﬁ-
cant side eﬀects and lower HRQOL (particularly
in physical domains) relative to the norms, young
adults who were transplanted as children were
accomplishing age-appropriate academic, per-
sonal, and professional milestones. However, it
should be noted that the number of studies
reporting long-term outcome data for survivors
of pediatric organ transplantation are few in
number and have largely been conducted in
North America.
Qualitative studies of long-term adjustment
Several qualitative studies also shed some light
on the experiences of organ transplant recipients
that may not easily emerge from quantiﬁable
data. Interviews with transplant patients revealed
that the most salient theme was a desire to
achieve a sense of normalcy (31, 32), emphasizing
development of their own identity, peer accep-
tance, wanting to feel free and energetic, and
ensuring strong support as the facilitating factors
of better QoL. On the opposing side, identity cri-
sis, peer rejection (being teased for their appear-
ance due to side eﬀects), aversion to medications,
lifestyle limitations, and feelings of fear and
uncertainty about graft survival were identiﬁed
as potential barriers. In a group of children who
had undergone an organ transplant in Canada
and their parents, semi-structured interviews
were conducted and subjected to qualitative con-
tent analysis (i.e., code identiﬁcation, category
saturation, theme generation). The children
expressed diﬃculties with adherence, fear of nee-
dles, restriction on activities, and medication side
eﬀects, while their parents were concerned with
post-transplant complications and self-manage-
ment as the children got older (33). A qualitative
study, using semi-structured interviews and
adopting a grounded theory approach (i.e., a
methodology that develops theory from an
analysis of patterns and common themes identi-
ﬁed in observational research), was undertaken
with 27 adolescents who had undergone heart
transplantation (median age at interview:
15.5 yr; median time since transplant: 3.2 yr)
(34). The results revealed a diversity of psycho-
logical, physical, and social well-being factors
which are important determinants of QoL.
Patients described the experience of a “transplant
journey” with stages, each with unique chal-
lenges such as “the struggle to survive” pretrans-
plant (e.g., diminished ability to participate in
activities, pain), “diﬃcult transitions” when man-
aging the transplant surgery (e.g., accepting
someone else’s heart, hospitalization, school
reintegration) and ﬁnally “an awakening and
transformation” post-transplant (e.g., feeling
that life is more vibrant, return to normalcy,
improved self-perception, enhanced interper-
sonal relationships and altered life philosophy).
The study described how young people are not
only able to adapt to transplantation, but may
also experience enhanced psychological and emo-
tional growth and life satisfaction.
Psychological adjustment of pediatric transplant recipients
Findings on emotional and behavioral function-
ing among solid organ transplant recipients have
been mixed, with some studies showing adjust-
ment comparable to that of healthy samples,
while other studies suggest impaired functioning.
Some early work (35, 36) documented generally
good-to-excellent adjustment in physical, psycho-
logical, and family domains several years after
children received a liver transplant. Relationships
with peers, feeling lonely, and socialization skills
were rated as more problematic, however. In a
larger study of 146 patients aged between four
and 25 yr (mean 10.32  4.31 yr) who had
undergone liver transplantation between 24–150
months previously (median: 74 months, with all
but three patients transplanted for more than
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three yr) older, but not younger, recipients per-
ceived themselves as less competent than their
healthy peers (37). This study also reported
gender diﬀerences, with adolescent boys and
young adult males obtaining signiﬁcantly higher
internalizing and total behavior problem scores
than healthy norms, whereas the scores for
females aged between 12 and 25 yr did not diﬀer
from those of their healthy counterparts. More
recently, a Finnish sample of 32 school-aged
renal transplant recipients (mean age: 9.6 
1.6 yr) who had been transplanted before the age
of ﬁve yr (38) had total scores on the Child
Behavior Checklist in the normal range. How-
ever, somatic complaints, social problems, and
attention diﬃculties were reported more fre-
quently in the transplant population compared
with healthy norms. A study investigating inter-
nalizing problems among pediatric renal and
liver transplant patients (mean time since trans-
plant 5.97 + 4.13 yr) found that hope and uncer-
tainty predicted levels of depression and anxiety
over a three-month period, with depression medi-
ating the relationship between hope and adher-
ence (25). In a further study, parents of pediatric
kidney and liver transplant patients (time since
transplant 6.2  4.1 yr) reported them to have
internalizing problems on the BASC-2 but chil-
dren themselves did not endorse psychosocial
issues outside of the normal range (26).
Fewer studies have examined long-term
adjustment after pediatric heart transplantation.
A sample of adolescents who received a heart
transplant in infancy overall scored within nor-
mal limits on measures of psychosocial function-
ing, self-concept, and QoL, with worse outcomes
for general health perception and bodily pain
and discomfort, with about a quarter of the sam-
ple at risk for long-term adjustment diﬃculties
(39). Speciﬁcally, deﬁcits were noted in the areas
of social skills and isolation from peers by
20–24% of the parents and 15–23% of the
patients, as well as low self-esteem and self-con-
cept by about 30% of the parents and adoles-
cents. Additionally, 40% of parents and 25% of
patients reported behavior problems, attention
diﬃculties, depression and anxiety. These ﬁnd-
ings are similar to studies by DeMaso and col-
leagues (40), who reported that the majority of
the heart patients had good psychological func-
tioning that was within the normal range on
standardized measures about six to 12 yr after
transplantation (median time since transplant
9.6 yr) but 27% endorsed emotional diﬃculties.
They point out, however, that approximately
one-ﬁfth of the U.S. population has symptoms
of mental health disorders; thus these results are
comparable. Lastly, transplant recipients may
endure diﬃcult or distressing hospital experi-
ences in which they may have believed their life
was at risk. As such, researchers have examined
the prevalence of PTSD in pediatric transplant
patients and found rates to be elevated as com-
pared with the general population (41, 42). For
example, in a sample of 104 adolescents post-
solid organ transplant, 16% were found to meet
the threshold for PTSD, with an additional 14%
reporting symptom clusters of PTSD at a level
causing distress. These rates are higher than the
prevalence of PTSD among adolescents based on
data from the National Survey of Adolescents
using DSM-IV criteria, which reported a six-
month prevalence of 3.7% for boys and 6.3%
for girls (43). Furthermore, a small study of 19
adolescent liver transplant patients found a posi-
tive association between PTSD symptoms and
non-adherence with medication (42), further
highlighting the importance of considering the
impact of traumatic experiences frequently asso-
ciated with transplant.
Summary
Children who have undergone transplantation
are at increased risk for poor HRQOL,
impaired psychosocial adjustment, and family
distress. Despite these risks, studies have dem-
onstrated that pediatric transplant recipients
transition into young adulthood and achieve
age-appropriate developmental milestones.
Future studies are needed to further examine




Cognitive ability in childhood is a predictor of
educational achievement, later occupational out-
comes and health behaviors (44, 45) and thus is
an important consideration for the transplant
recipient. It is recognized that children who have
undergone solid organ transplantation are at
increased risk of cognitive impairment (46) and a
number of factors related to the underlying dis-
ease, transplant surgery and post-operative
course may be implicated in deﬁcits in cognitive
functioning. However, much of the existing liter-
ature reports either cross-sectional or longitudi-
nal post-transplant data only, thus limiting
determination of cause of impairments in func-
tioning. Furthermore, many of the studies are
single center and comprise small sample sizes
with a variable period of follow-up.
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Despite the limitations mentioned above,
there are some patterns emerging in terms of
cognitive ability in the longer-term after trans-
plant. A common ﬁnding is that transplant
recipients have overall levels of cognitive ability
which are in the normal to low normal range
but that a greater proportion score in the
below average range than is seen in the healthy
population (47–55). For example, in a study of
64 liver transplant recipients at an average of
nine yr after liver transplantation, mean IQ
scores on the WISC-IV were in the lower nor-
mal range and scores on verbal comprehension,
perceptual reasoning and processing speed were
signiﬁcantly below those of a group of age-
and gender-matched healthy children. Com-
pared to the children in the reference group,
twice as many children in the transplant group
obtained total IQ scores of <70 (9.4% vs.
4.7%). Lower height percentile at transplant
and a diagnosis of a genetic-metabolic disease
were associated with poorer cognitive function-
ing (47). Similarly, a study of 12 children diag-
nosed in infancy with end-stage renal failure
who had undergone transplantation at an aver-
age of 31 months found mean scores on the
WISC-IV at a minimum of three yr after trans-
plant to be at least one standard deviation
below the mean, with full-scale IQ scores sig-
niﬁcantly lower than those of sibling controls
(56). Younger age at transplant was associated
with higher scores on measures of processing
speed, and full-scale IQ and processing speed
were negatively correlated with total months
on dialysis prior to transplant. Results for
heart transplant recipients follow a similar pat-
tern, with low-average mean full-scale IQ
scores and a higher proportion of children
obtaining scores in the below average range
compared with healthy norms (39, 57, 58). In
one study of 55 primary school children who
had undergone heart transplantation in
infancy, mean IQ scores were in the low-aver-
age range (59). A number of operative (e.g.,
bypass time), longer-term medical (e.g., number
of serious infections), and socioeconomic fac-
tors were associated with performance on cog-
nitive and academic tests. More recently,
children bridged to transplant with a VAD
have been compared with those not requiring
bridging and while the number of VAD
patients was very small (n = 6) the ﬁndings
indicated that at a median of 54 months after
transplant those who had been treated with a
VAD did not diﬀer on measures of cognitive
function from those not requiring bridging to
transplant (60).
Academic achievement
Assessment of academic achievement indicates
that solid organ recipients perform less well than
do their healthy peers in the later years after
transplant. Interpretation of results is again lim-
ited by small sample sizes and cross-sectional
studies, together with a lack of standardization
in the measures used to assess academic perfor-
mance. In one of the few longer-term follow-up
studies, scores on measures of academic achieve-
ment were in the low-average to average range
for a group of 21 adolescents (aged 12–17 yr)
who underwent heart transplantation in infancy
(39), with 30–45% performing in the borderline
to impaired range on the arithmetic, reading,
and/or spelling scales. However, academic scores
were higher than expected based on overall cog-
nitive scores, which the authors suggest indicates
that their ability to learn is “intact.” Below/low
average academic abilities have been documented
for other groups of heart, heart–lung, liver, and
kidney recipients with mathematical and spelling
abilities seemingly more impaired than are read-
ing skills (53, 58, 61). There is no clear reason
why reading skills seem to be less impaired than
arithmetic, but transplant recipients do appear to
be at an increased risk for non-verbal learning
diﬃculties (59). A further issue may be related to
the tests used to assess academic abilities, with
those used to assess reading being less sensitive
and therefore less able to identify diﬃculties, par-
ticularly in older children.
Other areas of functioning
Children and adolescents late after transplant are
also at risk for impairments in a number of other
domains, including visuospatial functioning,
memory, expressive and receptive language, exec-
utive function and attention (39, 52, 57, 62–64),
although these domains have been less well stud-
ied than cognitive or academic functioning and
there are limited data on long-term neuropsycho-
logical outcomes. Studies typically have small
sample sizes and are cross-sectional in nature.
Comparison of study results reveals few consis-
tent patterns but impaired visual-motor integra-
tion has been identiﬁed in several groups of
patients (39, 57, 59, 62, 63). In a number of stud-
ies, working memory was found to be impaired,
which it has been suggested was due to the toxic-
ity of corticosteroids to the hippocampus, a
structure important for learning and memory
(39, 47, 50, 52). However, this is not a consistent
ﬁnding—for example, in a small (n = 18) study
of liver recipients children obtained lower visual-
motor integration scores but performance on
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tasks assessing attention, learning and memory
was in the normal range (57). There have been
some attempts to look at correlates of poorer
function—for example, in a study of 50 renal
patients, verbal working memory and complex
(but not simple) auditory attention were associ-
ated with poorer renal function (52). However, it
is clear that further longitudinal evaluation of
larger patient groups is necessary before any con-
clusions can be drawn about risk factors for spe-
ciﬁc neuropsychological outcomes. Although the
evidence base to inform the choice of domains to
assess is somewhat limited, the ﬁndings suggest
that visual-motor integration and memory in
particular should be assessed. The neurocogni-
tive vulnerability of children and adolescents
after transplantation is clearly an important con-
sideration, particularly when planning educa-
tional services and assessing academic and social
performance in the school environment (65).
Learning support
More than a third of children and adolescents
who have undergone solid organ transplantation
have learning disabilities (39, 65, 66). In some
cases, this will have been present prior to trans-
plant but in other situations it may be at least in
part attributable to the surgery, subsequent treat-
ment, and missed schooling. For example, in one
study of renal transplant recipients, two of 26
children attended a special school purely due to
hearing problems which developed after the
transplant (48), supporting ﬁndings that high lev-
els of tacrolimus can result in sudden hearing loss
after transplant, with signiﬁcant psychosocial
and educational consequences (67). While a pro-
portion of transplant recipients attend schools
for children with learning disability or receive
additional learning support, within mainstream
schooling there is little in the literature describing
the school experience for children and adoles-
cents who have undergone transplantation (65).
Furthermore, where research has been con-
ducted, the focus has been on school re-entry
and the early years after transplant, with very
little mention of the later years. School perfor-
mance is an important functional outcome for
school-aged children (68), but cognitive and
academic delays in transplant recipients appear
to be frequently under-recognized in the school
environment, thus precluding early intervention
and targeted learning support (53).
Summary
Children who have undergone transplantation
are at increased risk for cognitive, neuropsycho-
logical and academic impairment, particularly
those who have been transplanted for congenital
disorders or who had prolonged periods of criti-
cal illness after transplant. Small sample sizes
and cross-sectional study design limit our ability
to identify speciﬁc risk factors but more recent
registry studies are now beginning to address
that. Professionals working in health and educa-
tion need to be better informed about the risks of
cognitive and academic impairment following
solid organ transplantation so that problems can
be identiﬁed early and appropriate support put
in place.
Adolescent issues post-transplantation
As survival rates continue to improve, an
increasing proportion of long-term survivors will
have to negotiate the additional challenges of
adolescence, although the focus of research in
this area has been on the young person trans-
planted in adolescence, rather than on the issues
for those who become an adolescent in the later
years after their transplant. However, there are a
few studies which have speciﬁcally investigated
variables unique to adolescence. Puberty may be
delayed in young people post-transplant (69, 70)
and there may therefore be periods when adoles-
cent transplant recipients are smaller and less
developed than then peers, which can impact on
their developing self-identity and adjustment.
Nedilskyj and colleagues examined body image
satisfaction and explored its relationship with
self-concept, depression, and social stress among
31 adolescents who received a heart transplant in
infancy or childhood (mean age at transplant
2.4  5.4 yr; time since transplant 13.6 
5.4 yr) (22). When comparing the transplant par-
ticipants to non-clinical controls no diﬀerences
were found in body image satisfaction, but the
relationship between these variables was more
salient for the healthy sample.
The need to establish a sense of self is probably
the most important developmental challenge met
by adolescents (71). Adolescents with a chronic
condition such as those who have undergone
transplantation have to cope with an extra chal-
lenge: that of integrating one’s identity as a per-
son with a chronic health condition with other
dimensions of one’s identity, to experience one’s
life and illness as challenges worth living. Risks
may arise and translate into self-management
diﬃculties when an adolescent’s identity as a per-
son with a chronic illness overshadows other
identities (72). Illness centrality refers to the
extent to which the illness experience plays a cen-
tral role versus a role that is more peripheral to
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the individual’s self-deﬁnition, and there is some
evidence that illness centrality is detrimental to
the development of self-care abilities (72–74).
Only one study was found which speciﬁcally
examined the concept of identity formation in
transplanted adolescents (75). Eighty-ﬁve adoles-
cents with a renal transplant or diabetes were
found to have more diﬃculty gaining indepen-
dence and establishing peer relationships in
school, leading to delayed identity development
(“diﬀusion”) relative to healthy controls, who
achieved “foreclosure” of identity. These ﬁndings
highlight challenges that are unique to adoles-
cents due to their desire for autonomy, which is
diﬃcult to achieve when grappling with a chronic
illness, and their concerns about body image due
to their heightened self-consciousness about
physical appearance. Collectively, ﬁndings indi-
cate that even when pediatric transplant recipi-
ents achieve medical stability and perhaps
improved QoL, challenges remain in speciﬁc
areas of psychosocial adjustment, namely social
interactions and concerns about physical
appearance.
Regimen adherence and self-management
Non-adherence to the post-transplant care plan
is associated with signiﬁcant consequences for all
patients including graft rejection, overall post-
transplant mortality, other increased medical
complications, psychological distress, family dys-
function, and poor HRQOL (14, 15, 76, 77).
Dimensions of non-adherence include medica-
tion non-adherence, failure to attend clinic
appointments and tests, and non-adherence with
lifestyle recommendations, such as diet, exercise,
tobacco, and substance use. Among all pediatric
transplant recipients, non-adherence with immu-
nosuppressive medications is estimated to be as
high as 50–65% (78–83). Adolescent transplant
recipients are at an increased risk for medication
non-adherence. Indeed, the prevalence of medi-
cation non-adherence has been documented to
be higher in adolescents (30–53%) than among
adults (15–25%) (84) and younger children
(3–19%) (81). Conversely, meta-analysis that
included 61 articles by Dew et al. in 2009 (85)
showed relatively modest non-adherence rates in
pediatric patients on all these aspects as com-
pared to adult patients in another meta-analysis
by the same authors (86). Indeed, whereas the
expected non-adherence rate in adult patients
would be 23% per year, it is only 6% per year in
adolescent patients (85). Unsurprisingly, the age
of the recipient was found to be signiﬁcantly
associated with non-adherence. These data
support adolescence as a risk factor for regimen
non-adherence (81, 84, 87–89). Moreover, non-
adherence also correlated with greater distress
and poorer psychosocial functioning in both the
recipient and the family (85). Non-adherence in
pediatric transplant recipients has the potential
to negatively impact long-term health outcomes
and QoL, particularly in those instances when it
persists during the transition from pediatric to
adult-centered health care (90, 91).
Unfortunately, there is a lack of randomized
controlled trials investigating the eﬀectiveness of
adherence-promoting interventions among pedi-
atric transplant recipients. Self-management has
been eﬀective in improving medication adherence
in children with other chronic health conditions
(92, 93). Key elements of self-management
include the promotion of health education, com-
munication skills, decision-making and problem-
solving skills, and self-care (94). A meta-analysis
by Kahana et al. (95) that included 32 studies on
psychological interventions to promote treat-
ment adherence in pediatric patients with chronic
health conditions, showed that behavioral or
multicomponent interventions (as opposed to
educational interventions) are the most eﬀective
to enhance adherence in pediatric patients. In
general, adherence is likely to be improved when
the burden of transplant and treatment are
reduced; for example, by simplifying medication
regimens, ensuring that young people have a good
understanding of the rationale for treatment,
opportunities to ask questions, realistic goals,
and appropriate behavioral strategies to minimize
forgetting or organizational diﬃculties (96).
In order to successfully promote improved
self-management in adolescents healthcare
providers need to be familiar with their develop-
mental needs and adapt health services accord-
ingly. In the ﬁeld of pediatric transplantation,
preliminary studies have demonstrated the utility
of peer networks in the promotion of self-man-
agement skills among adolescent transplant
recipients. Encouraging ﬁndings have been
reported from Harden and colleagues’ integrated
transition pathway for young people post kidney
transplant (97). This utilizes community-based
clinics and integrated peer support, facilitated by
a youth worker. Over a four-yr period, none of
the 12 young people had lost their grafts, as com-
pared with 67% of the nine young people in the
previous six-yr period under a simple adult trans-
fer model.
In addition to developing relationships among
adolescents of a similar age, a recent study dem-
onstrated other potential beneﬁts of a peer
mentor program (98). Nine young people (aged
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16–30 yr) were trained to take a leadership role
in supporting younger post-transplant patients.
As compared with a waiting list control group,
the peer mentors evidenced clinically signiﬁcant
decreases in the variability of their mean trough
tacrolimus blood levels ([s.d.]; indicating an
improvement in adherence to medication), but
no signiﬁcant changes in their self-rated self-
management skills or HRQOL. The program
was shown to be feasible, and mentors described
it as highly acceptable. These studies highlight
the potential beneﬁts of peer support in improv-
ing self-management in young people post-trans-
plant throughout their adolescence and as they
transition into adult services. Further research
with larger sample sizes is needed to evaluate the
best means of facilitating peer support networks
and the range of beneﬁts this might bring.
The use of emerging technology to deliver
adherence-promoting interventions is also
increasing. For example, Miloh et al. (99) found
that a text message reminder intervention signiﬁ-
cantly increased medication adherence rates, as
measured by reduction in the mean tacrolimus
level SD and reductions in the number of epi-
sodes of rejection. As part of improving accessi-
bility and approachability of services, transplant
services for young people beneﬁt from using
developmentally appropriate communication,
including text and email.
Transition of self-managed care within the family
Self-management skills are integral to both opti-
mal medication adherence and the achievement
of independence necessary for successful health-
care transitions (100, 101). To enable adolescents
to develop into successful young adults, their
families also need to adjust their roles to allow
for their increased independence and responsibil-
ity (102). This process can be complex in young
people who have had transplants, particularly
those who are many years out from their initial
surgery, as their families often have long-stand-
ing relationships with the transplant team and
have taken responsibility for their child’s care.
Age has been shown to be associated with
increased patient responsibility for health man-
agement in a pediatric transplant population
(103–105). However, older adolescents/young
adults are also known to be at higher risk for
non-adherence to their recommended treatment
regimen; thus this transition to independence can
be challenging (90, 106). There is evidence from
qualitative work with adolescent liver transplant
recipients that managing the transition of
responsibility for key tasks, such as managing
medication and attending appointments alone, is
a process which can present challenges (107,
108). In a mixed methods study of adolescents
who had undergone renal transplantation, 70%
of participants had their parents taking primary
responsibility for medication management (109).
Navigating the transition of responsibility from
parent to adolescent can have an inﬂuence on
medication adherence. For example, among
pediatric kidney transplant recipients, increased
patient–parent disagreement regarding AoR was
signiﬁcantly associated with medication non-
adherence as measured by electronic medication
monitoring devices (MEMS TrackCaps) (103).
The Allocation of Treatment Responsibility
Scale (103), which has demonstrated acceptable
psychometric properties in families of children
with a kidney transplant, could be useful for
assessing how medical regimen tasks are divided
between patients and their caregivers, with
potential beneﬁts for monitoring adherence and
transition readiness, particularly for those ado-
lescents transplanted as young children.
Adjustment of parents and families
The role of parents and family in child health has
been long recognized. Among pediatric trans-
plant recipients, low QoL has been linked with
family conﬂict, disruption of family activities,
and lack of family cohesion (14, 110–112). In
addition, increased stress related to parenting a
child with a chronic health condition has been
shown to be associated with lower child QoL (14,
112). Therefore, it is important to consider the
psychological functioning of parents when
addressing psychological and QoL parameters of
children and adolescents. Research on caretakers
of children following an organ transplant has
mostly focused on adjustment during the pre-
transplant period and the early years after the
surgery. The long-term psychosocial outcomes of
parents caring for a child years after a transplant
are sparse. What is known is that about a quarter
of parents report a burden on their time, an
impact on their emotional functioning and dis-
ruption in family activities (11, 13, 21, 39). An
investigation of the long-term psychological
functioning among parents of pediatric heart
transplant recipients reported that 40% of the
parents (mostly mothers) endorsed moderate to
severe post-traumatic stress symptoms, and 19%
met criteria for PTSD (113). These rates are
much higher than the prevalence of PTSD
among adults in the U.S., estimated to be 6.8%
by the National Comorbidity Survey Replication
study completed in 2003 (114).
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Parents in this sample also had signiﬁcantly
higher rates of general psychological distress rel-
ative to normative adult samples. In addition,
parents of transplant patients report more diﬃ-
culties in managing the child’s illness on the Pedi-
atric Inventory for Parents relative to parents of
diabetes patients, but comparable to parents of
patients with cancer (15). Another study relayed
that parents experienced stress related to their
child’s illness more frequently than did parents
of patients with cancer, but endorsed less diﬃ-
culty in managing the stress. Greater disease
severity of their child’s condition impacted the
parents’ psychological outcomes, more so than
did demographic variables or time since trans-
plant. Interestingly, despite the diminished QoL,
the emotional toll on parents, and the disruption
to the family routine, studies report stable family
functioning and family cohesion (13, 15).
Limitations and future directions
Current studies are limited by methodological
diﬀerences making it diﬃcult to draw conclu-
sions across studies, and across organ transplant
populations. The majority of research studies
compared QoL and psychological functioning of
transplant recipients to healthy controls; a few
studies made comparisons to functioning prior
to transplant or in relation to other chronic ill-
ness groups. One consideration is whether it is
fair to compare functioning to that of healthy
controls, as children and adolescents continue to
manage a demanding life-long regimen with
potential for medical complications. Perhaps
improved QoL after the transplant and a consis-
tent stable or upward trend over the long haul
should be the goal.
There were slight diﬀerences in the docu-
mented outcomes which may be attributed to
varying measurements utilized (e.g., PedsQL,
CHQ, SF-36) and whether the authors chose to
report overall scores vs. functioning in speciﬁc
domains. As most of these studies have been con-
ducted, the Transplant Module has been devel-
oped for the PedsQL with good validity and
reliability to the Generic Core Module (6). Thus,
researchers may elect to include this measure to
ensure that they are assessing QoL domains that
are focused on the transplant process and that
would ensure more consistency across studies. It
is also recommended that future studies include
parent-proxy and patient self-report, as impor-
tant diﬀerences in the perception of HRQOL are
likely to arise.
Evaluating long-term outcomes in pediatric
solid organ transplant recipients is also
inﬂuenced by the variable deﬁnition of “the later
years.” Many studies investigating psychosocial
outcomes in post-transplant recipients include
patients spanning wide age ranges, and broad
time post-transplant (e.g., 12 months-20 yr).
This makes conclusions about how psychosocial
functioning relates to physical milestones at
intervals comparable to the published UNOS
data on patient or graft survival data (e.g., three,
ﬁve, 10 yr) diﬃcult. Further, when the time since
transplant is reported there is variability in the
type of statistics that are provided (average time
vs. median number of years) making valid com-
parison of the ﬁndings across studies challeng-
ing.
Most of the studies have utilized cross-sec-
tional research design, documenting outcomes at
a given point in time. How HRQOL and adjust-
ment changes over time after a transplant, partic-
ularly at critical developmental milestones, is not
clear from this body of the literature. In addition,
not knowing the baseline level of functioning
prior to or even immediately after the transplant
surgery makes the interpretation of long-term
outcomes diﬃcult. That is, even when QoL
scores are lower relative to healthy patients that
may still mean that functioning has improved
dramatically since their end-stage disease state.
Without prospective longitudinal research, it is
unclear yet whether these diﬃculties had previ-
ously existed prior to transplant but were not as
salient relative to other areas of functioning or
whether as the patients get older the gap in
socialization is widened, becoming more pro-
nounced.
Finally, it is clear from the literature that kid-
ney and liver transplant recipients, and to a lesser
extent heart recipients, have been the focus of
most of the research addressing functioning in
the longer term, with very little attention being
given to recipients of lung or small bowel trans-
plants. While this may be a reﬂection of the smal-
ler numbers of patients and their poorer
outcomes, these groups are now increasing in
both numbers of transplants performed and
duration of survival, making longer-term evalua-
tion a possibility.
Recommendations for future research
The importance of regular testing and screening,
including later after transplantation, is now
being recognized (68, 115), together with the
need to identify brief, reliable and valid
assessment measures (116), and clinical and
treatment-related correlates and predictors of
post-transplant outcome are also being
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identiﬁed. Research to date is limited by small,
largely cross-sectional studies, using diﬀerent
assessment tools and involving varying follow-up
periods, and it is often diﬃcult to tease out early
and later follow-up data. However, involvement
of multiple centers, increasing use of databases
and transplant registries and a more rigorous
approach to psychological follow-up with larger
cohorts of patients, such as that adopted by the
Functional Outcomes Group of the SPLIT con-
sortium (117), will help to address some of these
limitations and provide the evidence to inform
interventions and optimize outcomes for pediat-
ric transplant recipients.
A further topic which has been poorly
addressed later after transplant is the role of
sociocultural factors. Maloney, Clay, and Robin-
son propose a STEM to enable practitioners to
explore the interaction of sociocultural factors
with each stage of transplant, including families’
health beliefs and adherence. As the number of
transplants being undertaken in culturally and
ethnically diverse populations continues to
increase it will be important to address these fac-
tors from both a clinical and research perspective
(118).
Finally, adherence and adolescent manage-
ment of treatment regimens are key areas where
evidence-based interventions need to be imple-
mented. Randomized controlled trials of non-
clinical interventions are few and far between in
pediatric transplantation but adherence is one
area where a trial with well-deﬁned and measur-
able outcomes would be very valuable.
Conclusions
The survival rates for pediatric solid organ trans-
plant recipients have increased dramatically, and
attention has shifted to focus on determining
optimal long-term outcomes, which include opti-
mizing graft function as well as enhancing
HRQOL and psychosocial functioning. Future
studies should continue to focus on the assess-
ment of psychosocial functioning in the years
post-transplant, but should also begin to test
interventions to promote HRQOL, adherence,
and the transition to adulthood.
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